Publikationen in Zusammenarbeit mit Forschern von Novo Nordisk (2)

2024

  1. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

    The Lancet, Vol. 404, Núm. 10454, pp. 773-786

2019

  1. Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial

    Diabetes, Obesity and Metabolism, Vol. 21, Núm. 3, pp. 499-508